Stop TB Partnership

GDF Facts & Figures

  • Years of existence: 8
  • Total funds raised for GDF operations: $268 million
  • Number of patient treatments supplied to date: 13,910,758
  • Number of countries that have received first-line drug deliveries: 88
  • Number of countries that have received second-line deliveries: 42
  • Number of High Burden Countries that received drugs through a Grant or Direct Procurement Service: 17
  • Number of countries that have received diagnostic kits deliveries: 17
  • Number of countries receiving GDF drugs: 93
  • Number of Technical assistance missions conducted: 334
  • Duration of GDF grants: 3 years (renewable)
  • Number of Global Fund recipients that have used GDF's services: 50
  • Average cost to treat a patient infected with drug-sensitive TB: $22.40
  • GDF's operational costs (as percentage of funding): 5
  • Primary funders of GDF grants and DP drug orders: UNITAID and The Global
  • Fund

Last updated: July 2009

Please email us at gdf@who.int for the most recent facts and figures.

GDF

Iso

GDF is ISO 9001:2000 compliant for provision of quality-assured anti-TB drugs and related services to eligible national TB control programmes.